DJIA 16,351.38 293.03 1.82%
NASDAQ 4,749.98 113.87 2.46%
S&P 500 1,948.86 35.01 1.83%
market minute promo

NxStage Medical (NASDAQ: NXTM)

16.95 0.35 (2.11%)

REAL-TIME: Last trade at

Extended Hours: $16.95 $0.00 (0.02%)
Quote as of (NASDAQ)

company name or ticker

Recent Quotes

NXTM $16.95 2.11%
1D 1W 3M 6M 1Y 2Y 3Y
Today's Open $16.72
Previous Close $16.60
Daily Range $16.61 - $17.03
52-Week Range $11.50 - $19.63
Market Cap $1.1B
P/E Ratio -46.11
Dividend (Yield) $0.00 (0.0%)
Volume 544,340
Average Daily Volume 636,138
Current FY EPS -$0.31




Healthcare IT

NxStage Medical (NXTM) Description

A medical device company, which develops, manufactures and markets innovative systems for the treatment of end-stage renal disease and acute kidney failure. Website:

News & Commentary Rss Feed

NxStage Medical Keeps Growing, Sees Even Better Times Ahead

The dialysis-services company saw solid revenue growth and raised its guidance for the full 2015 year.

Notable Two Hundred Day Moving Average Cross - NXTM

Insider Trading Alert - PPBI, DXPE And NXTM Traded By Insiders

NXTM January 2016 Options Begin Trading

Nxstage (NXTM) Shares March Higher, Can It Continue?

NxStage Medical's (NXTM) CEO Jeff Burbank on Q2 2015 Results - Earnings Call Transcript

Nxstage Medical Soars Following Better-Than-Expected Q2 Results

2:30pm ET: Nxstage Medical stock rises as much as 13% out of the gate following market-topping Q2 results, but has since settled into gains of around 7%.

NxStage Medical (NXTM) Q2 2015 Results - Earnings Call Webcast

Structurally Light On Growth, Baxter Has A Lot Of Work Ahead

Point 72 Takes A 5% Stake In NxStage Medical

See More NXTM News...

NXTM's Top Competitors

NXTM $16.95 (2.11%)
Current stock: NXTM
MDT $71.55 (2.91%)
Current stock: MDT
$0.00 (0.00%)
Current stock:
COV $0.00 (0.00%)
Current stock: COV